ImmunoGen (IMGN) - P/S ratio

P/S ratio on April 12, 2024 (TTM) : 30.3

According to ImmunoGen 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 15.5. At the end of 2023 the company had a P/S ratio of 13.7.

P/S ratio history for ImmunoGen from 2001 to 2023

PS ratio at the end of each year

Year	P/S ratio	Change
2023	13.7	36.47%
2022	10.1	-56.95%
2021	23.4	146.29%
2020	9.49	1.9%
2019	9.32	-30.57%
2018	13.4	82.73%
2017	7.34	65.72%
2016	4.43	-78.65%
2015	20.8	192.92%
2014	7.08	-57.08%
2013	16.5	-80.15%
2012	83.2	105.47%
2011	40.5	-1.53%
2010	41.1	70.95%
2009	24.0	281.05%
2008	6.31	40.15%
2007	4.50	-19.89%
2006	5.62	-14.58%
2005	6.58	-36.27%
2004	10.3	-40.27%
2003	17.3	2.2%
2002	16.9	-86.3%
2001	123

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Seagen SGEN	18.8	-38.15%	🇺🇸 USA
Amgen AMGN	4.98	-83.58%	🇺🇸 USA
Eli Lilly LLY	19.0	-37.29%	🇺🇸 USA
Bristol-Myers Squibb BMY	2.52	-91.68%	🇺🇸 USA
Johnson & Johnson JNJ	4.21	-86.13%	🇺🇸 USA
Pfizer PFE	2.72	-91.03%	🇺🇸 USA
Novartis NVS	4.20	-86.15%	🇨🇭 Switzerland
Sanofi SNY	2.40	-92.08%	🇫🇷 France

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for ImmunoGen (IMGN)

P/S ratio on April 12, 2024 (TTM) : 30.3